Business · Markets · 1 hr ago
Analyst recommends tracking Glenmark Pharma, Karur Vysya Bank and Go Digit
Sachin Gupta, a research vice-president at Choice Broking, recommended buying shares in three Indian companies: Glenmark Pharma, Karur Vysya Bank and Go Digit General Insurance.
He gave a target price of ₹2,450 and a stop-loss price of ₹2,200 for Glenmark Pharma.
For Karur Vysya Bank, his target was ₹370 and his stop-loss was ₹320.
For Go Digit, he set a target range of ₹300 to ₹305 and a stop-loss of ₹257.
The recommendations are based on recent share-price patterns and technical indicators, including support levels and trading momentum.
Gupta said Glenmark had rebounded from a key support area, Karur Vysya had recovered from a recent decline, and Go Digit had broken above a chart pattern that can signal a possible trend change.
These are analyst views, and the recommendations do not guarantee that the shares will reach their targets; no further developments are given.
Sachin Gupta of Choice Broking recommended tracking Glenmark Pharma, Karur Vysya Bank and Go Digit General Insurance.
He recommended buying Glenmark Pharma at ₹2,290, with a stop loss of ₹2,200 and a target of ₹2,450.
For Karur Vysya Bank, he recommended buying at ₹340, with a stop loss of ₹320 and a target of ₹370.
For Go Digit General Insurance, he recommended buying at ₹273, with a stop loss of ₹257 and a target of ₹300/305.
The recommendations were based on technical signals including support levels, moving averages and momentum indicators.
- Who
- Sachin Gupta, vice-president of research at Choice Broking.
- What
- He recommended buying Glenmark Pharma, Karur Vysya Bank and Go Digit General Insurance, with specified entry prices, stop losses and targets.
- When
- The article was published on October 12, 2026.
- Where
- Not stated.
- Why
- The analysis cited technical signals, including price recoveries, moving averages, a chart breakout and supportive momentum.
This story does not have two clearly opposing sides.
No direct quotes in the coverage so far.
This story does not have a timeline yet.
- Glenmark Pharma entry
- ₹2,290
- Glenmark Pharma target
- ₹2,450
- Karur Vysya Bank entry
- ₹340
- Karur Vysya Bank target
- ₹370
- Go Digit entry
- ₹273
- Go Digit target
- ₹300/305
Sources
Related news
Amundi Research Arm Sees Indian Stocks Rebounding After Iran War
RBI moves to support the rupee, but longer-term pressure remains
RBI Steps Up Rupee Defense as Crude Costs and Outflows Weigh
Indian stocks in focus as companies report results and new orders
Festive e-commerce sales reach Rs 24,000 crore in two days as VC funding falls
Indian stocks set for a slightly higher open as Asian markets diverge
India draft policy targets 604 million tonnes of steel capacity by 2047
India opens dollar window for oil companies to support the rupee
FMCG sales expected to grow, but rising costs may squeeze margins
Nifty ends losing streak but technical outlook remains weak
HCL Tech set to report Q2 earnings as investors watch growth and guidance